IBBL (Integrated BioBank of Luxembourg) Institute


Main axes of research

The IBBL (Integrated BioBank of Luxembourg) Institute is a biobank dedicated to supporting biomedical research for the benefit of patients.

IBBL is an integrated research infrastructure, compliant with international quality standards, offering biobanking services, including the collection, processing, analysis and storage of biological samples and associated data. In addition, IBBL carries out research to optimise biospecimen processing and certify biospecimen quality.

IBBL’s vision is to be an international centre of excellence in biobanking and to accelerate the introduction of personalised healthcare for the benefit of the people of Luxembourg.

To accomplish these aims, IBBL has a series of strategic goals for the immediate future:

  • To support biomedical research in Luxembourg, specifically in the domain of personalised medicine
  • To grow sample collections and the number of partners & clients
  • To increase the visibility of Luxembourg’s biomedical & biotechnology sector 

IBBL is an autonomous institute, organised within the Luxembourg Institute of Health (LIH).


Current research projects

IBBL partners with other Luxembourg-based and foreign medical research institutions for a variety of projects. IBBL currently supports priority research programmes focused on:


The initial focus of the cancer programme is lung cancer and IBBL is working together with the Partnership for Personalised Medicine (PPM), including the Luxembourg Institute of Health (former CRP-Santé), the Fred Hutchison Cancer Research Centre, and the Translational Genomics Research Institute (TGen) since its inception in 2008. In 2011, the project expanded to include colon and breast cancers. The aim of this programme is to identify and validate new molecular tools that would allow early diagnosis of disease or help to provide patients in Luxembourg with the best personalised cancer therapy available.


The diabetes research team based at the University of Luxembourg has embarked on two studies which analyse families with diabetes mellitus in an attempt to learn something about the gene-environment influences known to be involved in the predisposition and onset of diabetes.

Parkinson’s’ Disease

IBBL is working in partnership with the Luxembourg Centre for Systems Biomedicine (LCSB) at the University of Luxembourg, and the Centre Hospitalier du Luxembourg (CHL), to identify biomarkers associated with Parkinson’s disease, in the hope of improving options for those diagnosed.

To maximise the knowledge gained from those projects and encourage collaborative research ventures in the future, a shared Computational Analysis Group has been created to devise the mathematical and software approaches needed to store, integrate and interpret the wealth of complex data.

Resources and collaborations


Infrastructure for appropriate storage and processing of biospecimens and associated data; advanced technology platforms for genomic and transcriptomic analysis.


Products and services

IBBL hosts a human specimen repository that oversees the acquisition of high quality samples and data, together with a biorefinery and advanced technology platforms for genomic and proteomic analysis. This supports translational research projects, especially research to facilitate the establishment of personalised medicine. Support is provided to collaborating groups, and also on a fee-for-service basis. IBBL operates a quality management system to ensure the highest operating standards are met in our laboratories and readily shares this expertise with partners. Since 2014, IBBL is ISO 9001:2008 and NF S96-900:2011 certified.


Major partnerships and collaborations

IBBL collaborates with organisations and individuals on biospecimen collection projects, research, industrial projects, through the provision of samples to clients, and partners with the International Society for Biological and Environmental Repositories (ISBER) to provide Proficiency Testing (PT) schemes to the biobanking community.IBBL also participates in large multi-national research programmes and is an ideal biobanking partner for FP7 or IMI projects.

Partners and clients include: 

  • The 5 major hospitals in Luxembourg
  • Laboratoire National de Santé (LNS)
  • Luxembourg Institute of Health
  • The University of Luxembourg
  • Luxembourg Centre for Systems Biomedicine
  • BD (Becton, Dickinson and Company)WaferGen Biosystems
  • JPND (EU Joint Programme Neurodegenerative Disease) 


Additional information

IBBL is a member of the following organisations:

  • International Society for Biological and Environmental Repositories (ISBER);
  • Public Project in Population Genomics (P3G);


Human resources

  • 9 Researchers (Prof., ass. Prof., Post-docs, PhD)
  • 0 Doctoral students and students
  • 0 Engineers
  • 17 Technicians
  • 16 Other

Business sector(s)

  • Life Sciences, health and biotechnology


IBBL (Integrated BioBank of Luxembourg) Institute
6, rue Nicolas Ernest Barblé, L-1210, Luxembourg
Phone: +352 27 44 64 1
Fax: +352 27 44 64 64
Email: communications@ibbl.lu
Site: http://www.ibbl.lu

R&D Contact

Dr LARUE Catherine
Chief Executive Officer
Phone: +352 27 44 64 1
Email: communications@ibbl.lu

R&D Contact

Communications Manager
Phone: +352 27 44 64 24
Email: Arnaud.dagostini@ibbl.lu

  • Updated 29-06-2015